Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNAs are crucial in cancer development, with let-7a often downregulated.
• The specific role and mechanisms of let-7a in Ewing sarcoma (ES) remain largely unclear.
• let-7a expression is reduced in human ES cells compared to mesenchymal stem cells.

Purpose of the Study:

• To investigate the functional effects of let-7a restoration in ES cells.
• To identify the molecular targets of let-7a in ES.
• To elucidate the therapeutic potential of targeting the let-7a/CDK6 axis in ES.

Main Methods:

• Exogenous transfection of let-7a mimic into ES cell lines (A673, SK-ES-1).
• Assessment of cell proliferation, migration, invasion, cell cycle, and apoptosis.
• Bioinformatic prediction, mRNA/protein expression analysis, and luciferase assays to identify and validate let-7a targets.
• Evaluation of the impact of restored CDK6 expression on let-7a's tumor-suppressive effects.

Main Results:

• Restored let-7a expression significantly inhibited ES cell proliferation, migration, and invasion.
• let-7a expression led to cell cycle arrest and induced apoptosis in ES cells.
• Cyclin-dependent kinase 6 (CDK6) was identified as a direct target of let-7a in ES.
• Restored CDK6 expression partially reversed the tumor-suppressive effects of let-7a.

Conclusions:

• let-7a functions as a tumor suppressor in Ewing sarcoma by directly targeting CDK6.
• The let-7a/CDK6 pathway represents a potential therapeutic target for Ewing sarcoma.
• This study provides insights for novel diagnostic and therapeutic strategies for ES.